Journals / Flora İnfeksiyon Hastalıkları ve Klinik Mikrobiyoloji Dergisi / 2020 / Cilt: 25 - Sayı: 2

The First Case of Urosepsis Due to Multidrug Resistant Pseudomonas fulva

Çoklu İlaç Dirençli Pseudomonas fulva’nın Etken Olduğu İlk Ürosepsis Olgusu

Pages
269–274
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

To our knowledge, there was no literature on multi drug resistant P. fulva.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Pseudomonas fulva is a non-fermenter gram-negative rod belonging to the Pseudomonas putida complex.
📊
Key Findings & Data:P. fulva was first reported to be an infectious agent in humans in 2010 and led to a hospital outbreak in Beijing in 2014, as well as a few individual cases from different countries.
💡
Conclusion & Impact:To our knowledge, there was no literature on multi drug resistant P. fulva.
🔬Design:Research Article
📍Scope:2010 Verileri
⚙️Variables:Domain Parameters

Abstract

Pseudomonas fulva is a non-fermenter gram-negative rod belonging to the Pseudomonas putida complex. Although it is one of the most common Pseudomonas species in nature, human infections due to P. fulva are very rare. P. fulva was first reported to be an infectious agent in humans in 2010 and led to a hospital outbreak in Beijing in 2014, as well as a few individual cases from different countries. There is no case report from our country in the literature. In this article, we present a case of urosepsis caused by P. fulva in a patient with chronic lymphocytic leukemia and autoimmune hemolytic anemia. The isolate detected in the case was resistant to all antibiotics except colistin. To our knowledge, there was no literature on multi drug resistant P. fulva.

Özet

Pseudomonas fulva, Pseudomonas putida kompleksi içinde yer alan nonfermenter gram-negatif basildir. Doğada en sık bulunan Pseudomonas türlerinden biri olmakla beraber, P. fulva’ya bağlı insan infeksiyonları çok nadirdir. İlk kez 2010 yılında insanda infeksiyon etkeni olarak bildirilen P. fulva, farklı ülkelerden münferit olguların yanı sıra 2014 yılında Pekin’de hastane salgını etkeni olarak saptanmıştır. Literatürde ülkemizden bildirilen olguya rastlanmamıştır. Bu yazıda kronik lenfositik lösemi ve otoimmün hemolitik anemisi olan bir hastada P. fulva’nın neden olduğu bir ürosepsis olgusu sunulmaktadır. Olguda saptanan izolat, kolistin dışındaki tüm antibiyotiklere dirençliydi. Literatürde çoklu ilaç dirençli P. fulva izolatına rastlanmamıştır.

🔖

Cite This Article

UZUNER, N., ÖZCAN, N., KANGÜL, H., KADANDIR, İ. R. (2020). The First Case of Urosepsis Due to Multidrug Resistant Pseudomonas fulva. Flora İnfeksiyon Hastalıkları ve Klinik Mikrobiyoloji Dergisi, Cilt: 25 - Sayı: 2, 269–274. https://ajindex.com/articles/160375

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (9)

  1. Rebolledo PA, Vu CCL, Carlson RD, Kraft CS, Anderson EJ, Burd EM. Polymicrobial ventriculitis involving Pseudomonas fulva. J Clin Microbiol 2014;52:2239-41
  2. Uchino M, Shida O, Uchimura T, Komagata K. Recharacterization of Pseudomonas fulva Iizuka and Komagata 1963, and proposals of Pseudomonas parafulva sp. nov. and Pseudomonas cremoricolorata sp. nov. J Gen Appl Microbiol 2001;47:247-61
  3. İlktaç M, Eser Ö, Güran M, Cömert F, Yurdakul P, Cevahir N, et al. Nonfermentatif gram-negatif basiller. In: Procop GW, Church DL, Hall GS, et al. (editors). Color Atlas and Textbook of Diagnostic Microbiology-Türkçe Baskısı. 7th ed. Ankara: Hipokrat Kitabevi, 2017:316-431
  4. EUCAST. European Committee on Antimicrobial Susceptibility Testing Breakpoint Tables for Interpretation of MICs and Zone Diameters-Version 8.0.; 2018. Erişim Tarihi: 17.02.2020. Available from: http://www.eucast.org/fileadmin/ src/media/PDFs/EUCAST_files/Breakpoint_tables/ v_8.0_Breakpoint_Tables.pdf 5. Remold SK, Brown CK, Farris JE, Hundley TC, Perpich JA, Purdy ME. Differential habitat use and niche partitioning by Pseudomonas species in human homes. Microb Ecol 2011;62:505-17
  5. Sivolodskii EP, Zueva EB, Kunilova ES, Bogumil’chik EA, Domakova T V. The identification of clinical strains Pseudomonas fulva using techniques of MALDI-TOF mass spectrometry and common analysis. Klin Lab Diagn 2015;60:46-9
  6. Almuzara MN, Vazquez M, Tanaka N, Turco M, Ramirez MS, Lopez EL, et al. First case of human infection due to Pseudomonas fulva, an environmental bacterium isolated from cerebrospinal fluid. J Clin Microbiol 2010;48:660-4
  7. Seok Y, Shin H, Lee Y, Cho I, Na S, Yong D, et al. First report of bloodstream infection caused by Pseudomonas fulva. J Clin Microbiol 2010;48:2656-7
  8. Liu Y, Liu K, Yu X, Li B, Cao B. Identification and control of a Pseudomonas spp. (P. fulva and P. putida) bloodstream infection outbreak in a teaching hospital in Beijing, China. Int J Infect Dis 2014;23:105-8
  9. Cobo F, Jimenez G, Rodriguez-Granger J, Sampedro A. Posttraumatic skin and soft-tissue infection due to Pseudomonas fulva. Case Rep Infect Dis 2016;2016:1-2.